z-logo
Premium
Drug Interaction Studies With CYP3A Substrates: How Much Inhibitor Pre‐exposure Is Needed?
Author(s) -
Greenblatt David J.
Publication year - 2012
Publication title -
clinical pharmacology in drug development
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.711
H-Index - 22
eISSN - 2160-7648
pISSN - 2160-763X
DOI - 10.1177/2160763x12448745
Subject(s) - ketoconazole , pharmacology , drug , clearance , medicine , cyp3a , drug interaction , pharmacokinetics , metabolism , antifungal , cytochrome p450 , dermatology , urology

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom